C

CTI CAPITAL

26 employees

CTI Capital is a venture capital fund that invests in development-stage, Canadian life sciences companies.

Investor insights

Sectors invested in

Biotechnology3
Health Diagnostics2
Medical Device2
Health Care1
Medical1
Genetics1

Funding rounds participated in

$26M sweet spot round size

Most of their 5 investments are in rounds between $193K and $50M

Investor type

Venture Capital

Basic info

Industry

capital markets

Sectors

Biotechnology
Pharmaceutical
Venture Capital

Date founded

1987

Investments made

U

Undisclosed raised $193K on January 18, 2022

Investors: CTI CAPITAL

X

Xagenic raised $26M on July 14, 2014

Investors: Domain Associates and CTI CAPITAL

X

Xagenic raised $10M on January 30, 2012

Investors: QIAGEN and CTI CAPITAL

E

Enobia Pharma raised $50M on August 10, 2009

Investors: Desjardins Entreprises - Capital régional et coopératif, OrbiMed Advisors and CTI CAPITAL

U

Undisclosed raised $75M on March 31, 2000

Investors: Temasek, Toshiba Corporation, ST Telemedia, ABN AMRO Energy Transition Fund, The Carlyle Group and CTI CAPITAL

FAQ